#USA #Healthcare Leadership #Portsmouth #Chris Smith #Laborie Medical

Laborie Medical Technologies Welcomes Chris Smith as New CEO

Laborie Medical Technologies Corp., a prominent player in the medical technology field, has announced a significant leadership shift with the appointment of Chris Smith as its new Chief Executive Officer. This change will take effect on September 22, 2025. Smith will succeed Michael Frazzette, who announced his retirement after a noteworthy tenure.

The New Leader’s Background

Chris Smith is no stranger to the medical technology and healthcare landscape. With over 30 years of executive leadership experience, he has made a mark in various notable organizations.
Previously, he held the CEO position at NeoGenomics Laboratories, Ortho Clinical Diagnostics, and Cochlear Limited, where he was instrumental in driving transformative growth and innovative initiatives. Smith also brings a wealth of governance experience, having served on the boards of both private and public companies. His expansive background positions him well for leading Laborie's next chapter.

Reflecting on Frazzette's departure, David Perez, Chair of the Board, expressed gratitude for the latter's impactful contributions during his leadership. "The Laborie Board of Directors thanks Mike for his outstanding contributions to Laborie during his tenure as CEO," Perez stated, highlighting the legacy of excellence that Frazzette leaves behind.

Acknowledging the Transition

In a statement about the transition, Yuriy Prilutskiy, Co-Head of Patricia Industries, noted the remarkable growth Laborie has experienced under Frazzette's stewardship. "During this time, Laborie has achieved significant growth, expanded its product portfolio and global presence, and fostered an innovative, high-performance culture," Prilutskiy remarked. The confidence expressed in Smith's capabilities underscores the board's expectations for further advancement under his leadership.

Vision and Commitment

In his upcoming role, Smith recognizes the mission of Laborie as pivotal to the company's ethos. "Laborie's mission truly resonates with me, and I'm excited to work with such an exceptional team as we continue to drive innovation and enhance patient lives in our three leading platforms: urology, gastroenterology, and OB," Smith said. His passion for the company’s objectives signals a rejuvenated focus on innovation and excellence.

As Laborie prepares for this transition, welcome sessions will be organized to introduce Smith to employees and partners throughout the company's global framework. This initiative illustrates the importance of fostering strong relationships and collaboration moving forward.

About Laborie Medical Technologies

Based in Portsmouth, New Hampshire, Laborie is at the forefront of medical technology, concentrating on areas like urology, urogynecology, gastroenterology, obstetrics, gynecology, and neonatal health. The company is recognized for manufacturing and delivering high-quality diagnostic and therapeutic products that prioritize patient dignity. Clinicians trust Laborie as a market leader, supported by comprehensive education and information programs focused on its product offerings.
Laborie operates under the umbrella of Patricia Industries, which seeks to enhance each company's potential through strategic investment and development.

With Chris Smith at the helm, Laborie is poised to continue its trajectory of innovation and excellence, reinforcing its commitment to enhancing patient care through transformative medical technologies.

For more information, visit Laborie's official website.